Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   - « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Russello, Maurizio
ARTE, NCT06806579: Atezolizumab-bevacizumab and Other Immunotherapies: Real-life Experience for Treatment of Hepatocellular Carcinoma	Recruiting	N/A	1000	Europe		IRCCS Azienda Ospedaliero-Universitaria di Bologna	Hepatocellular Carcinoma (HCC)	10/30	10/31
NCT05618145: National Database on Primary Sclerosing Cholangitis (PSC)	Recruiting	N/A	6000	Europe	Clinical information	University of Milano Bicocca	Primary Sclerosing Cholangitis	10/32	10/32

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Russello, Maurizio
ARTE, NCT06806579: Atezolizumab-bevacizumab and Other Immunotherapies: Real-life Experience for Treatment of Hepatocellular Carcinoma	Recruiting	N/A	1000	Europe		IRCCS Azienda Ospedaliero-Universitaria di Bologna	Hepatocellular Carcinoma (HCC)	10/30	10/31
NCT05618145: National Database on Primary Sclerosing Cholangitis (PSC)	Recruiting	N/A	6000	Europe	Clinical information	University of Milano Bicocca	Primary Sclerosing Cholangitis	10/32	10/32